Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Sci Food Agric ; 92(13): 2644-51, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22495778

RESUMO

BACKGROUND: The aim of this work was to evaluate the effects of polyphenol-rich adzuki bean extract on lipid metabolism, triglyceride accumulation and proinflammatory cytokine secretion in vivo and in vitro. RESULTS: For the in vivo study, rats were divided into four groups: group C was fed a control diet, group A was fed the control diet with 1% adzuki bean extract, group CF was fed a high fat diet, and group AF was fed a high fat diet with 1% adzuki bean extract. For the in vitro study, the ability of adzuki bean extract to suppress triglyceride incorporation, glycerol phosphate dehydrogenase activity and inflammatory response was investigated in cultured human adipocytes. Data from the animal study showed that adzuki bean extract improved lipid metabolism in both the normal and high-fat diet groups. Adzuki bean extract treatment in the high-fat group resulted in significant reductions in total hepatic lipid accumulation and lipid secretion into the feces. Incubation of adipocytes with adzuki bean extract significantly decreased triglyceride accumulation, glycerol phosphate dehydrogenase activity and inflammatory responses without affecting cell viability. CONCLUSION: The results of this study demonstrate that adzuki bean extract has high potential to serve as a natural anti-obesity agent.


Assuntos
Adipócitos/efeitos dos fármacos , Fabaceae/química , Metabolismo dos Lipídeos/efeitos dos fármacos , Obesidade/prevenção & controle , Fitoterapia , Extratos Vegetais/uso terapêutico , Polifenóis/uso terapêutico , Adipócitos/metabolismo , Animais , Fármacos Antiobesidade/farmacologia , Fármacos Antiobesidade/uso terapêutico , Citocinas/metabolismo , Dieta Hiperlipídica/efeitos adversos , Fezes , Humanos , Inflamação/prevenção & controle , Mediadores da Inflamação/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Obesidade/metabolismo , Oxirredutases/metabolismo , Extratos Vegetais/farmacologia , Polifenóis/farmacologia , Ratos , Ratos Endogâmicos F344 , Sementes/química , Triglicerídeos/metabolismo
2.
J Food Sci ; 76(1): H2-6, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21535684

RESUMO

Based on previous research findings, a capsule was developed containing n-3 polyunsaturated fatty acid rich scallop phospholipids (PLs) with an incorporation of brown seaweed (Undaria pinnatifida) lipids (ULs) containing fucoxanthin. The antiobesity effects of the capsules were evaluated with an animal model using 3-wk-old male KK-A(y) mice. Each group received different combinations of lipid (UL, PL, UL + PL, or UL + PL capsule) either incorporated into the diet or into drinking water. Animals were sacrificed after a 4-wk experimental feeding period, and adipose tissues and organs were dissected and weighed. Blood samples were obtained to determine plasma lipid profiles. Uncoupling protein 1 (UCP1) mRNA expression levels were determined by real-time polymerase chain reaction analysis, and UCP1 expression was determined by western blotting analysis. Treatment with either UL alone or UL + PL (capsule) through drinking water resulted in a significant reduction in body weight, compared to the control group. The total white adipose tissue weight of mice fed the UL + PL capsule in drinking water was significantly reduced. Both UCP1 and UCP1 mRNA expression in epididymal fat from mice fed the capsule were significantly higher than in the control group. These results suggest that incorporation of UL into scallop-derived PL by means of capsulation may lead to an additive increase in the antiobesity properties of these bioactive lipids.


Assuntos
Fármacos Antiobesidade/uso terapêutico , Suplementos Nutricionais , Ácidos Graxos Ômega-3/uso terapêutico , Obesidade/prevenção & controle , Pectinidae/química , Undaria/química , Xantofilas/uso terapêutico , Tecido Adiposo Branco/metabolismo , Adiposidade , Animais , Fármacos Antiobesidade/análise , Fármacos Antiobesidade/química , Suplementos Nutricionais/economia , Ácidos Graxos Ômega-3/análise , Indústria de Processamento de Alimentos/economia , Regulação da Expressão Gênica , Resíduos Industriais/análise , Resíduos Industriais/economia , Canais Iônicos/genética , Canais Iônicos/metabolismo , Lipídeos/sangue , Lipídeos/química , Lipídeos/uso terapêutico , Masculino , Camundongos , Camundongos Obesos , Proteínas Mitocondriais/genética , Proteínas Mitocondriais/metabolismo , Nanocápsulas/uso terapêutico , Obesidade/sangue , Obesidade/metabolismo , Fosfolipídeos/sangue , Fosfolipídeos/química , Fosfolipídeos/uso terapêutico , RNA Mensageiro/metabolismo , Distribuição Aleatória , Alga Marinha/química , Proteína Desacopladora 1 , Xantofilas/administração & dosagem , Xantofilas/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA